Agranulocytosis and secondary infection related to JAK inhibitors and IL-6 receptor blockers: a disproportionality analysis using the US Food and drug administration adverse event reporting system
Chunyan Wei, Wanhong Yin, Tingting Hu, Jingyi Zhang, Huifang Dan, Bin Wu · 2024
Read Agranulocytosis and secondary infection related to JAK inhibitors and IL-6 receptor blockers: a disproportionality analysis using the US Food and drug administration adverse event reporting system by Chunyan Wei, Wanhong Yin, Tingting Hu, Jingyi Zhang, Huifang Dan, Bin Wu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10803638.txt.
Description
Chunyan Wei and co-authors mine United States drug safety reports for a rare blood disaster in a study dated 2023. Two drug families used against immune disease, JAK inhibitors and interleukin-6 blockers, can suppress the bone marrow. The feared event is agranulocytosis, a collapse of infection-fighting white cells.
Over 211,000 reports were pulled from the federal database spanning 2004 to 2022. Every drug in both families showed a statistical link to secondary infection, and the link strengthened when the families were combined. The analysis also tracked the marrow event rates drug by drug, giving prescribers a real-world risk picture beyond trial data.
Catalog record
| CREATOR | Chunyan Wei, Wanhong Yin, Tingting Hu, Jingyi Zhang, Huifang Dan, Bin Wu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |